Status:
COMPLETED
Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery
Lead Sponsor:
Fundacio Puigvert
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare pain level (according to numerical score)at 4, 8, 12 and 24 postoperative hours between patients under transverse abdominal plain blockade (TAP) and patients un...
Eligibility Criteria
Inclusion
- \> 18 yrs.
- Patients undergo laparoscopic urologic surgery
- Physical status ASA \< 3
- Surgical procedure without complications
- Signed informed consent
Exclusion
- Allergy to bupivacaine chlorhydrate
- Patients with chronic pain treatment
- Alcoholism
- Decompensated hepatic disease
- Coagulation disorders
- BMI \> 35
- Patient involved in another clinical trial
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT01501565
Start Date
December 1 2011
End Date
November 1 2012
Last Update
November 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundació Puigvert
Barcelona, Barcelona, Spain, 08025